Brainsway (BWAY) Other Non-Current Liabilities (2020 - 2025)
Brainsway (BWAY) posted quarterly Other Non-Current Liabilities of $5.0 million for Q4 2025, down 13.34% year-on-year from $5.8 million in Q4 2024, and up 4.14% on a QoQ basis from $4.8 million in Q3 2025.
Brainsway (BWAY) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Brainsway (BWAY) has reported Other Non-Current Liabilities for 6 consecutive years, with $5.0 million the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 13.34% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (down 13.34% YoY) and the FY2025 annual result came in at $5.0 million, down 13.34% from the prior year.
- Other Non-Current Liabilities rose to $5.0 million in Q4 2025 per BWAY's latest filing, from $4.8 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for BWAY reached as high as $6.1 million in Q4 2023 and fell as low as $2.1 million in Q1 2025.
- A 5-year average of $5.2 million and a median of $5.7 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities gained 7.19% — and 2025, when it fell 13.34%.
- Year by year, Other Non-Current Liabilities stood at $5.9 million in 2021, then increased by 1.6% to $6.0 million in 2022, then increased by 1.01% to $6.1 million in 2023, then retreated by 4.51% to $5.8 million in 2024, then dropped by 13.34% to $5.0 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $5.0 million, $4.8 million, and $5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.03 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 5.80 Mn |
| Dec 31, 2023 | 6.08 Mn |
| Dec 31, 2022 | 6.02 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Dec 31, 2020 | 5.52 Mn |